STARTRADER CEO Peter Karsten Joins University of Europe for Three Sessions Spanning AI Infrastructure, Business Operations, and Market Risk
Across three sessions in Dubai this spring, the conversations moved from how AI agents are built and reshaping business operations to whether the market's pricing of the build-out can hold. DUBAI, UAE, May 22, 2026 /PRNewswire/ -- Peter Karsten, CEO...
STARTRADER CEO Peter Karsten Delivers 'AI Starter' Keynote at University of Adelaide
DUBAI, UAE, May 20, 2026 /PRNewswire/ -- The online address marks an early step in STARTRADER's commitment to youth education in artificial intelligence and future skills. STARTRADER CEO Peter Karsten Delivers 'AI Starter' Keynote at University of...
Agilent and Singapore's NATi Partner to Advance Lipid-Conjugated Oligonucleotide Research
Collaboration expands research of new delivery platform beyond liver tissues supporting potential preclinical development and strengthens Singapore's position as a biomedical innovation hub SINGAPORE, May 20, 2026 /PRNewswire/ -- Agilent...
STARTRADER Posts $3.145 Trillion in Q1 2026 Trading Volume, Up 340% Year-on-Year
The record quarter marks a new growth phase for the global multi-asset broker. DUBAI, UAE, April 28, 2026 /PRNewswire/ -- STARTRADER has revealed its highest quarterly trading volume to date. The global multi-asset broker achieved $3.145 trillion in...
ClavystBio and A*STAR Partner to Grow MedTech Ventures in Singapore
SINGAPORE, June 10, 2025 /PRNewswire/ -- ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have signed a...
SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore
SCG Cell Therapy signed a Memorandum of Understanding (MoU) with A*STAR Bioprocessing Technology Institute (A*STAR BTI) and Nucleic Acid Therapeutics Initiative (NATi) to advance ribonucleic acid (RNA)-based therapeutic manufacturing process...